Cargando…

Immunosuppressive Phenotype of Esophagus Tumors Stroma

BACKGROUND: Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) contribute significantly to the development of immunosuppressive properties of a tumor. In this study, we performed immunohistochemical analysis of immune cells of esophageal tumors stroma. METHODS: Paraffin-em...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovaleva, Olga V., Rashidova, Madina A., Samoilova, Daria V., Podlesnaya, Polina A., Mochalnikova, Valeria V., Gratchev, Alexei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455837/
https://www.ncbi.nlm.nih.gov/pubmed/32884895
http://dx.doi.org/10.1155/2020/5424780
_version_ 1783575699622199296
author Kovaleva, Olga V.
Rashidova, Madina A.
Samoilova, Daria V.
Podlesnaya, Polina A.
Mochalnikova, Valeria V.
Gratchev, Alexei
author_facet Kovaleva, Olga V.
Rashidova, Madina A.
Samoilova, Daria V.
Podlesnaya, Polina A.
Mochalnikova, Valeria V.
Gratchev, Alexei
author_sort Kovaleva, Olga V.
collection PubMed
description BACKGROUND: Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) contribute significantly to the development of immunosuppressive properties of a tumor. In this study, we performed immunohistochemical analysis of immune cells of esophageal tumors stroma. METHODS: Paraffin-embedded tissue specimens from 48 esophageal squamous cell carcinoma (ESCC) patients were retrospectively collected for immunohistochemical analysis of stromal cells. For staining of macrophages, CD68, CD163, CD206, PU.1, and iNOS were used. For T cell detection, CD8, CD3, and FOXP3 were used. Also, we performed staining for PD-L1 that can be expressed on TAMs and tumor cells. Clinicopathological and survival data were collected and analyzed using the χ(2) and Fisher exact tests, Kaplan–Meier curves, and the log-rank test. The correlation analysis was performed with Spearman's rank correlation coefficient. RESULTS: We found that FOXP3 expression was associated with age (p = 0.042) and iNOS expression was associated with the disease stage (p = 0.044). In addition, FOXP3 and CD163 appeared to be markers of good prognosis (HR = 0.4420, p = 0.0325, and HR = 0.4447, p = 0.0456, respectively). Significant association between PU.1+ and CD68+ macrophages (r = 0.833; p ≤ 0.001) and between PU.1+ and CD163+ macrophages (r = 0.500; p ≤ 0.001) was established; positive association between PU.1 and CD206 expression was also observed (r = 0.250; p = 0.043). CONCLUSIONS: Large amounts of CD163+ macrophages and FOXP3+ Т cells appear to be markers of good prognosis of ESCC. The number of PU.1+ macrophages strongly correlates with the number of CD68+ macrophages; therefore, usage of PU.1 as a potential macrophage marker can be recommended for esophageal tumors.
format Online
Article
Text
id pubmed-7455837
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74558372020-09-02 Immunosuppressive Phenotype of Esophagus Tumors Stroma Kovaleva, Olga V. Rashidova, Madina A. Samoilova, Daria V. Podlesnaya, Polina A. Mochalnikova, Valeria V. Gratchev, Alexei Anal Cell Pathol (Amst) Research Article BACKGROUND: Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) contribute significantly to the development of immunosuppressive properties of a tumor. In this study, we performed immunohistochemical analysis of immune cells of esophageal tumors stroma. METHODS: Paraffin-embedded tissue specimens from 48 esophageal squamous cell carcinoma (ESCC) patients were retrospectively collected for immunohistochemical analysis of stromal cells. For staining of macrophages, CD68, CD163, CD206, PU.1, and iNOS were used. For T cell detection, CD8, CD3, and FOXP3 were used. Also, we performed staining for PD-L1 that can be expressed on TAMs and tumor cells. Clinicopathological and survival data were collected and analyzed using the χ(2) and Fisher exact tests, Kaplan–Meier curves, and the log-rank test. The correlation analysis was performed with Spearman's rank correlation coefficient. RESULTS: We found that FOXP3 expression was associated with age (p = 0.042) and iNOS expression was associated with the disease stage (p = 0.044). In addition, FOXP3 and CD163 appeared to be markers of good prognosis (HR = 0.4420, p = 0.0325, and HR = 0.4447, p = 0.0456, respectively). Significant association between PU.1+ and CD68+ macrophages (r = 0.833; p ≤ 0.001) and between PU.1+ and CD163+ macrophages (r = 0.500; p ≤ 0.001) was established; positive association between PU.1 and CD206 expression was also observed (r = 0.250; p = 0.043). CONCLUSIONS: Large amounts of CD163+ macrophages and FOXP3+ Т cells appear to be markers of good prognosis of ESCC. The number of PU.1+ macrophages strongly correlates with the number of CD68+ macrophages; therefore, usage of PU.1 as a potential macrophage marker can be recommended for esophageal tumors. Hindawi 2020-08-20 /pmc/articles/PMC7455837/ /pubmed/32884895 http://dx.doi.org/10.1155/2020/5424780 Text en Copyright © 2020 Olga V. Kovaleva et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kovaleva, Olga V.
Rashidova, Madina A.
Samoilova, Daria V.
Podlesnaya, Polina A.
Mochalnikova, Valeria V.
Gratchev, Alexei
Immunosuppressive Phenotype of Esophagus Tumors Stroma
title Immunosuppressive Phenotype of Esophagus Tumors Stroma
title_full Immunosuppressive Phenotype of Esophagus Tumors Stroma
title_fullStr Immunosuppressive Phenotype of Esophagus Tumors Stroma
title_full_unstemmed Immunosuppressive Phenotype of Esophagus Tumors Stroma
title_short Immunosuppressive Phenotype of Esophagus Tumors Stroma
title_sort immunosuppressive phenotype of esophagus tumors stroma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455837/
https://www.ncbi.nlm.nih.gov/pubmed/32884895
http://dx.doi.org/10.1155/2020/5424780
work_keys_str_mv AT kovalevaolgav immunosuppressivephenotypeofesophagustumorsstroma
AT rashidovamadinaa immunosuppressivephenotypeofesophagustumorsstroma
AT samoilovadariav immunosuppressivephenotypeofesophagustumorsstroma
AT podlesnayapolinaa immunosuppressivephenotypeofesophagustumorsstroma
AT mochalnikovavaleriav immunosuppressivephenotypeofesophagustumorsstroma
AT gratchevalexei immunosuppressivephenotypeofesophagustumorsstroma